Collins Stewart Europe

Collins Stewart Europe was a prominent independent investment bank and stockbroking firm headquartered in London, United Kingdom. The company provided a wide array of financial services, including corporate finance advisory, equity research, and wealth management, with a particular focus on mid-cap companies. While not a life sciences developer itself, the firm was a key player in the healthcare sector, facilitating capital raises and providing strategic advice to numerous biotechnology and medtech companies. It was well-regarded for its proprietary 'Quest' research platform and its significant presence on the London Stock Exchange's AIM market. In 2012, the firm was acquired by the Canadian financial group Canaccord Financial for approximately £253 million. Following the merger, its operations were rebranded and integrated into Canaccord Genuity.